We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





ADLM 2024 Showcases Breakthrough Innovations Shaping Future of Clinical Testing

By LabMedica International staff writers
Posted on 30 Jul 2024

The Association for Diagnostics & Laboratory Medicine (ADLM, Washington, DC, USA) is hosting the ADLM 2024 Clinical Lab Expo (formerly AACC Annual Scientific Meeting & Clinical Lab Expo) in Chicago from July 28 – August 1, 2024, showcasing breakthrough innovations that are shaping the future of clinical testing. More...

ADLM 2024 Clinical Lab Expo is the premier global laboratory medicine exposition and the place to learn about the breakthrough innovations shaping the future of clinical testing and patient care. Dedicated to achieving better health through laboratory medicine, ADLM brings together more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. This year, ADLM’s Clinical Lab Expo is providing attendees with access to nearly 900 exhibitors across 200+ product categories to learn about the latest technologies, services, and solutions for the lab and beyond. Attendees can visit the electronic billboard outside the Expo Hall entrance to learn about innovative new products and services. They will have the opportunity to interact with the showcase to obtain detailed product and service information. Attendees can also find out about new diagnostic breakthroughs and critical lab medicine developments in the Exhibit Hall Theaters, which are conveniently located on the Expo show floor.

Several changes have impacted laboratory medicine that is being reflected in ADLM 2024 in three main ways: greater intersection between laboratory medicine disciplines; integration of automation into the clinical microbiology space; and the increased leveraging and utilization of data analytics, including large language model artificial intelligence (AI) and data visualization. Another topic in focus at the meeting is how the clinical laboratory community can respond to the evolving landscape of laboratory-developed tests, particularly in light of the recent Food and Drug Administration (FDA) final ruling that will go into effect in May 2027.

Additionally, ADLM 2024 is bringing together global leaders for an immersive experience featuring 5 plenaries, nearly 70 scientific sessions, more than 170 roundtables, and a showcase of over 700 posters, offering something for everyone in laboratory medicine. Each day, Sunday – Thursday, the conference begins with a thought-provoking Plenary delivered as a keynote lecture by a world-renowned expert. Plenaries will address timely topics applicable to all laboratorians and span the breadth of research and medicine. Scientific Sessions represent the core of ADLM 2024 with nearly 70 sessions taking place from Monday – Thursday. Scientific Sessions present the latest scientific information on all aspects of laboratory medicine and include a variety of education formats, presentation styles, and audience engagements. Scientific Sessions also include specially developed and invited sessions from ADLM collaborations and divisions.

Roundtables are special ticketed sessions that take place from Monday – Wednesday as 1-hour interactive small group discussions with up to 10 participants. These small groups allow for a unique and highly engaging experience where participants get direct interaction with the presenter and opportunities to both learn and ask questions. Topics range across the spectrum of laboratory medicine and focus on practical skills and case examples. ADLM's Poster Hall provides a wide collection of 700+ poster presentations that take place on Tuesday and Wednesday as an open-access hall in the ADLM Clinical Lab Expo. Topics span the full breadth of laboratory medicine and often represent the latest in cutting-edge research. The ADLM Poster Hall is a unique opportunity to directly connect with poster presenters at their posters during unopposed presenter discussion periods. ADLM 2024 is also home to specially developed sessions and competitions. At a special session of ADLM’s Disruptive Technology Award Competition held in the plenary hall, three diagnostic developers are presenting data on their innovative technologies. A panel of expert judges will be evaluating all presented testing solutions based on feasibility and performance, and the audience will also vote for their favorite technology.

Related Links:
ADLM


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.